NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-051-1994-2-DE-12 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 DE EP 95906686.1 Expired
NCI E-051-1994-2-FR-14 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 FR EP 95906686.1 Expired
NCI E-051-1994-2-ES-13 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 ES EP 95906686.1 Expired
NCI E-051-1994-2-PT-20 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 PT EP 95906686.1 Expired
NCI E-051-1994-2-AU-02 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 AU National Stage 15168/95 Expired
NCI E-051-1994-1-US-01 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 US CIP 08/360,923 5674492 Expired PDF
NCI E-051-1994-2-NO-06 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 NO National Stage 962526 Expired
NCI E-051-1994-2-PCT-01 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 PCT PCT COMB PCT/US1994/014767 Expired
NHLBI E-189-1989-3-US-03 GENE THERAPY US CON 08/361,198 Abandoned
NCI E-261-2008-1-EP-01 Melanoma Associated Antigenic Polypeptide, Epitopes Thereof And Vaccines Against Melanoma EP ORD 94203709.4 Abandoned
NCI E-051-1994-2-JP-05 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 JP National Stage 517593/95 Expired
NCI E-051-1994-2-CA-03 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 CA National Stage 2179196 Abandoned
NCI E-157-1993-1-MX-09 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE MX National Stage 9409706 Abandoned
NCI E-157-1993-1-LU-21 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE LU EP 95909917.7 Abandoned
NCI E-157-1993-1-MC-22 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE MC EP 95909917.7 Abandoned
NCI E-157-1993-1-NL-23 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE NL EP 95909917.7 Abandoned
NCI E-157-1993-1-EP-12 MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RETROVIRAL SPREAD EP National Stage 95909917.7 Abandoned
NCI E-157-1993-1-AT-13 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE AT EP 95909917.7 Abandoned
NCI E-157-1993-1-BE-14 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE BE EP 95909917.7 Abandoned
NCI E-157-1993-1-IE-19 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE IE EP 95909917.7 Abandoned
NCI E-157-1993-1-GR-18 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE GR EP 95909917.7 Abandoned
NCI E-157-1993-1-IT-20 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE IT EP 95909917.7 Abandoned
NCI E-157-1993-1-SE-26 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE SE EP 95909917.7 Abandoned
NCI E-157-1993-1-CH-27 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE CH EP 95909917.7 Abandoned
NCI E-157-1993-1-PT-24 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE PT EP 95909917.7 Abandoned
NCI E-157-1993-1-ES-25 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE ES EP 95909917.7 Abandoned
NCI E-157-1993-1-DK-15 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE DK EP 95909917.7 Abandoned
NCI E-157-1993-1-GB-28 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE GB EP 95909917.7 Abandoned
NCI E-157-1993-1-FR-16 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE FR EP 95909917.7 Abandoned
NCI E-157-1993-1-DE-17 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE DE EP 95909917.7 Abandoned
NCI E-157-1993-1-CA-11 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYCARBAMIDE CA National Stage 2179627 Abandoned
NCI E-220-1994-0-US-01 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... US ORD 08/359,612 5728718 Abandoned PDF
NCI E-157-1993-1-TW-06 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE TW ORD 83111742 Abandoned
NCI E-157-1993-1-ZA-07 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE ZA National Stage 94/9219 Abandoned
NIDDK E-045-1989-0-US-03 SULFUR-CONTAINING XANTHINE DERIVATIVES AS ADENOSINE ANTAGONISTS US FWC 08/359,959 5453426 Expired PDF
NCI E-157-1993-1-PCT-03 No_Patent_Title PCT PCT PCT/US95/00153 Abandoned
NCI E-157-1993-1-AU-10 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE AU National Stage 18212/95 Abandoned
NCI E-157-1993-1-BR-04 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE BR National Stage PI1100041-4 Abandoned
NIAID E-189-1992-0-US-07 SYNTHETIC PEPTIDE VACCINE FOR CHLAMYDIA TRACHOMATIS US FWC 08/363,307 Abandoned
NCI E-157-1993-1-OA-05 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE OA National Stage 60849 Abandoned
NCI E-046-1995-0-US-01 SCREENING ASSAYS FOR COMPOUNDS THAT CAUSE APOPTOSIS AND RELATED COMPOUNDS US ORD 08/359,316 6602979 Abandoned PDF
NCI E-136-1992-0-US-07 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES US FWC 08/358,657 Abandoned
NHLBI E-232-1994-0-US-01 CHIRAL SEPARATION OF ENANTIOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY US ORD 08/357,845 6337021 Abandoned PDF
CC E-088-1994-1-US-01 VARIABLE AXIAL APERTURE POSITRON EMISSION TOMOGRAPHY SCANNER US CIP 08/357,574 5591977 Expired PDF
NCI E-216-1994-0-US-01 INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS US ORD 08/353,765 6057346 Abandoned PDF
NCI E-032-1995-0-US-01 SENSITIVE ASSAY FOR MEASURING GALLIUM LEVELS IN BODY TISSUES AND FLUIDS US ORD 08/355,153 5650627 Expired PDF
NIA E-239-1994-0-US-01 RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES US ORD 08/350,819 5571929 Expired PDF
NIDDK E-245-1992-0-US-03 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS US CON 08/348,654 5679679 Abandoned PDF
NCI E-162-1990-0-US-08 SUSTAINED AND CONTINUOUS PRODUCTION OF HIGH TITERS OF RECOMBINANT VIRAL VECTORS AND TRANSDUCED TARGET CELLS... US FWC 08/352,160 Abandoned
NIDDK E-245-1993-0-US-02 NITROGEN-CONTAINING CYCLOHETERO ALKY FUSED CYCLOAMINOARYL DERIVATIVES FOR CNS DISORDERS US CON 08/348,622 Abandoned